Extract notice to the Minister

Sandoz Lisdexamfetamine

Common name / Subject : lisdexamfetamine (dimesylate de)
Name of the manufacturer : Sandoz
Form :
Dosage :

Indication :

INESSS' Recommendation
Inscription - Avec conditions

Minister's decisions
Inscrire aux listes des médicaments - Médicament d'exception

Evaluation published on December 12, 2024

Subscribe to our newsletter now

Subscription